Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L S Manning

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
The Southern Medical Record|August 26, 2022
Puerperal EclampsiaL S Manning
British Journal of Cancer|November 27, 1999
Effects of the glucolipid synthase inhibitor, P4, on functional and phenotypic parameters of murine myeloma cellsL S Manning, N S Radin
Annals of the New York Academy of Sciences|June 30, 1983
Cellular determinants of mammary cell-mediated immunity in the rat: kinetics of lymphocyte subset accumulation in the rat mammary gland during pregnancy and lactationM J Parmely, L S Manning
Nursing|September 1, 1981
Teaching is a two way streetL S Manning, D J Young
Journal of Immunology (Baltimore, Md. : 1950)|December 1, 1980
Cellular determinants of mammary cell-mediated immunity in the rat. I. The migration of radioisotopically labeled T lymphocytesL S Manning, M J Parmely
Cellular Immunology|May 1, 1984
Macrophages in murine uterus are immunosuppressiveJ S Hunt, L S Manning, G W Wood
Clinical and Experimental Immunology|January 1, 1991
Asbestos fibres inhibit the in vitro activity of lymphokine-activated killer (LAK) cells from healthy individuals and patients with malignant mesotheliomaL S Manning, M R Davis, B W Robinson
Clinical and Experimental Immunology|October 1, 1990
In vivo boosting of lung natural killer and lymphokine-activated killer cell activity by interleukin-2: comparison of systemic, intrapleural and inhalation routesJ P Flexman, L S Manning, B W Robinson
International Journal for Parasitology|May 1, 1996
In vitro stage-specific sensitivity of Plasmodium falciparum to quinine and artemisinin drugsT S Skinner, L S Manning, W A Johnston, et al.
Clinical Immunology and Immunopathology|January 1, 1991
Capacity of tumor necrosis factor to augment lymphocyte-mediated tumor cell lysis of malignant mesotheliomaR V Bowman, L S Manning, M R Davis, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
The Southern Medical Record|August 26, 2022
Puerperal EclampsiaL S Manning
British Journal of Cancer|November 27, 1999
Effects of the glucolipid synthase inhibitor, P4, on functional and phenotypic parameters of murine myeloma cellsL S Manning, N S Radin
Annals of the New York Academy of Sciences|June 30, 1983
Cellular determinants of mammary cell-mediated immunity in the rat: kinetics of lymphocyte subset accumulation in the rat mammary gland during pregnancy and lactationM J Parmely, L S Manning
Nursing|September 1, 1981
Teaching is a two way streetL S Manning, D J Young
Journal of Immunology (Baltimore, Md. : 1950)|December 1, 1980
Cellular determinants of mammary cell-mediated immunity in the rat. I. The migration of radioisotopically labeled T lymphocytesL S Manning, M J Parmely
Cellular Immunology|May 1, 1984
Macrophages in murine uterus are immunosuppressiveJ S Hunt, L S Manning, G W Wood
Clinical and Experimental Immunology|January 1, 1991
Asbestos fibres inhibit the in vitro activity of lymphokine-activated killer (LAK) cells from healthy individuals and patients with malignant mesotheliomaL S Manning, M R Davis, B W Robinson
Clinical and Experimental Immunology|October 1, 1990
In vivo boosting of lung natural killer and lymphokine-activated killer cell activity by interleukin-2: comparison of systemic, intrapleural and inhalation routesJ P Flexman, L S Manning, B W Robinson
International Journal for Parasitology|May 1, 1996
In vitro stage-specific sensitivity of Plasmodium falciparum to quinine and artemisinin drugsT S Skinner, L S Manning, W A Johnston, et al.
Clinical Immunology and Immunopathology|January 1, 1991
Capacity of tumor necrosis factor to augment lymphocyte-mediated tumor cell lysis of malignant mesotheliomaR V Bowman, L S Manning, M R Davis, et al.
Pageof 3